EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

In patients taking fluticasone propionate/salmeterol 100/50mug Dislus for asthma, fluticasone propionate nasal spray 200mug QD is superior to montelukast 10mg QD in the treatment of allergic rhinitis in patients with coexistent allergic rhinitis Implication for the one airway hypothesis



In patients taking fluticasone propionate/salmeterol 100/50mug Dislus for asthma, fluticasone propionate nasal spray 200mug QD is superior to montelukast 10mg QD in the treatment of allergic rhinitis in patients with coexistent allergic rhinitis Implication for the one airway hypothesis



Journal of Allergy & Clinical Immunology 113(2 Supplement): S200, February




(PDF emailed within 1 workday: $29.90)

Accession: 035103285

Download citation: RISBibTeXText



Related references

In patients taking fluticasone propionate/salmeterol 100/50mug Diskus for asthma, the addition of fluticasone propionate nasal spray 200mug QD to treat concomitant allergic rhinitis has a safety profile comparable to the addition of montelukast 10mg QD or placebo. Journal of Allergy & Clinical Immunology 113(2 Supplement): S202-S203, February, 2004

Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. Chest 128(4): 1910-1920, 2005

Loss of asthma control when patients receiving fluticasone propionate/salmeterol 100/50mug Diskus are stepped-down to fluticasone propionate, salmeterol or montelukast alone. Journal of Allergy & Clinical Immunology 113(2 Supplement): S94, February, 2004

Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis. Allergy and Asthma Proceedings 31(1): 68-75, 2010

Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms. Annals of Allergy, Asthma & Immunology 96(6): 851-857, 2006

A comparative study of fluticasone propionate nasal spray and the combination of loratadine and montelukast in the treatment of seasonal allergic rhinitis. Journal of Allergy & Clinical Immunology 109(1 Supplement): S265, January, 2002

Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Annals of Allergy, Asthma & Immunology 100(1): 74-81, 2008

Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast. Annals of Allergy, Asthma & Immunology 90(5): 536-542, 2003

Once daily fluticasone propionate aqueous nasal spray controls symptoms of most patients with seasonal allergic rhinitis. Allergy (copenhagen). 50(10): 794-799, 1995

Fluticasone propionate aqueous nasal spray compared with oral loratadine in patients with seasonal allergic rhinitis. Allergy (copenhagen). 52(4): 445-450, 1997

Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis. Annals of Allergy 67(2 Pt 1): 156-162, 1991

Fluticasone propionate aqueous nasal spray relieves sinus pain and pressure in patients with allergic rhinitis. Journal of Allergy & Clinical Immunology 107(2): S154, February, 2001

Effect of fluticasone propionate nasal spray on bioavailability of intranasal hydromorphone hydrochloride in patients with allergic rhinitis. PharmacoTherapy 24(1): 26-32, 2004

Triamcinolone acetonide nasal spray vs fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis. Journal of Allergy & Clinical Immunology 97(1 PART 3): 433, 1996

Fluticasone propionate aqueous nasal spray reduces nasal eosinophils and cytokine activity of patients with allergic rhinitis. Journal of Allergy & Clinical Immunology 95(1 PART 2): 193, 1995